642 M. Guzmán
Sánchez C, Rueda D, Ségui B, Galve-Roperh I, Levade T, Guzmán M (2001b) The CB1
cannabinoid receptor of astrocytes is coupled to sphingomyelin hydrolysis through the
adaptor protein fan. Mol Pharmacol 59:955–959
Sarker KP, Biswas KK, Yamakuchi M, Lee KY, Hahiguchi T, Kracht M, Kitajima I, Maruyama
I (2003) ASK1-p38 MAPK/JNK signaling cascade mediates anandamide-induced PC12
cell death. J Neurochem 85:50–61
Scallet AC, Uemure E, Andrews A, Ali SF, McMillan DE, Paule MC, Brown RM, Slikker W
(1987) Morphometric studies of the rat hippocampus following chronic delta-9-tetra-
hydrocannabinol (THC). Brain Res 436:193–198
Schwarz H, Blanco FJ, Lotz M (1994) Anadamide, an endogenous cannabinoid receptor ago-
nist inhibits lymphocyte proliferation and induces apoptosis. J Neuroimmunol 55:107–
115
Shen M, Thayer SA (1998) Cannabinoid receptor agonist protect cultured rat hippocampal
neurons from excitotoxicity. Mol Pharmacol 54:459–462
Sinor AD, Irvin SM, Greenberg DA (2000) Endocannabinoids protect cerebral cortical
neurons from in vitro ischemia in rats. Neurosci Lett 278:157–160
Skaper SD, Buriani A, Dal Toso R, Petrelli L, Romanello S, Facci L, Leon A (1996) The
ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protec-
tive in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule
neurons. Proc Natl Acad Sci USA 93:3984–3989
Stella N, Schweitzer P, Piomelli D (1997) A second endogenous cannabinoid that modulates
long-term potentiation. Nature 388:773–778
ValkPJM,HolS,VankanY,IhleJN,AskewD,JenkinsNA,GilbertDJ,CopelandNG,deBoth
NJ, Löwenberg B, Delwel R (1997a) The genes encoding the peripheral cannabinoid re-
ceptor andα-L-fucosidase are located near a newly identified common virus integration
site, Evi11. J Virol 71:6796–6804
ValkP,VerbarkelS,VankanY,HolS,ManchamS,PloemacherR,MayenA,LöwenbergB,
Delwel R (1997b) Anandamide, a natural ligand for the peripheral cannabinoid receptor
is a novel synergistic growth factor for hematopoietic cells. Blood 90:1448–1457
Valk PJ, Vankan Y, Joosten M, Jenkins NA, Copeland NG, Löwenberg B, Delwel R (1999)
Retroviral insertions in Evi12, a novel common virus integration site upstream of
Tra1/Grp94, frequently coincides with insertions in the gene encoding the peripheral
cannabinoid receptor Cnr2. J Virol 73:3595–3602
Van der Stelt M, Veldhuis WB, Bär PR, Veldink GA, Vliegenthart JFG, Nikolay K (2001)
Neuroprotection by∆9-tetrahydrocannabinol, the main active compound of marijuana,
against ouabain-induced in vivo excitotoxicity. J Neurosci 21:6475–6479
Van der Stelt M, Veldhuis WB, Maccarrone M, Bar PR, Nicolay K, Veldink GA, Di Marzo V,
Vliegenthart JF (2002) Acute neuronal injury, excitotoxicity, and the endocannabinoid
system. Mol Neurobiol 26:317–346
Zajicek J, Fox P, Sanders H, Wright D, Vickery J, Nunn A, Thompson A, UK MS Research
Group (2003) Cannabinoids for treatment of spasticity and other symptoms related
to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial.
Lancet 362:1517–1526
Zhu W, Friedman H, Klein TW (1998)∆9-TetraHydroCannabinol induces apoptosis in
macrophages and lymphocytes: involvement of Bcl-2 and caspase-1. J Pharmacol Exp
Ther 286:1103–1109